Cefpodoxime Proxetil Granule, For Suspension
Product Images NDC 16714-403

5 FDA label images from Northstar Rx Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cefpodoxime Proxetil (NDC 16714-403). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (50 mg/5 mL (50 mL Bottle))

Package Label-principal Display Panel (50 mg/5 mL (50 mL Bottle))
Label for Cefpodoxime Proxetil 50 mg/5 mL oral suspension granules from NorthStar Rx LLC. The label includes preparation directions, storage instructions, and manufacturer information. The product is supplied as 50 mL when constituted and for oral use only, with warnings and handling instructions noted.*
FDA Label Image

Package Label-principal Display Panel (50 mg/5 mL Carton Label)

Package Label-principal Display Panel (50 mg/5 mL Carton Label)
Packaging label for Cefpodoxime Proxetil for Oral Suspension, USP 50 mg/5 mL granules for suspension by NorthStar Rx LLC. The label includes instructions for mixing and storage, a 50 mL quantity when constituted, and states the product is Rx only. Manufactured by Aurobindo Pharma Limited, India, for NorthStar Rx LLC, Memphis, TN.*
FDA Label Image

Package Label-principal Display Panel (100 mg/5 mL (50 mL Bottle))

Package Label-principal Display Panel (100 mg/5 mL (50 mL Bottle))
Label for Cefpodoxime Proxetil for Oral Suspension, USP 100 mg/5 mL granules for suspension in a 50 mL reconstituted bottle. The label includes mixing and storage directions, warnings, and manufacturer information by NorthStar Rx LLC, with manufacturing by Aurobindo Pharma Limited, India. The label also displays the NDC 16714-403-01 and a barcode.*
FDA Label Image

Package Label-principal Display Panel (100 mg/5 mL Carton Label)

Package Label-principal Display Panel (100 mg/5 mL Carton Label)
Packaging label for Cefpodoxime Proxetil for Oral Suspension, USP 100 mg/5 mL granules, for reconstitution to 50 mL suspension. The label includes mixing instructions and storage information. It displays NorthStar Rx LLC as the labeler and Aurobindo Pharma Limited as the manufacturer. The label features the NDC 16714-403-01 and highlights that the product is Rx only.*
FDA Label Image

Chemical Structure (Cefpodoxime Str)

Chemical Structure (Cefpodoxime Str)
Chemical structure of Cefpodoxime Proxetil, the active ingredient in this human prescription drug available as oral granules for suspension. The diagram depicts the molecular arrangement including the beta-lactam ring and ester groups characteristic of this cephalosporin antibiotic prodrug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.